AstraZeneca (AZN LN) EMA's CHMP adopted a positive opinion recommending a change to the terms of the marketing authorisation for AstraZeneca's Leqvio

#ASTRAZENECA PLC#AZN.LN#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#FTSE 100
Published: Updated: